Our findings are broadly concordant with those of Maglione et al. and Guerra-Galan et al. who also found individuals with XLA and CVID had reduced serum BCMA concentrations [5, 6]. The gene discussed is TNFRSF17; the disease is Bruton-type agammaglobulinemia.